Multi-modal treatment with peptide vaccine, metronomic cyclophosphamide and anti-PD1 monoclonal antibody provides effective control of tumors in multiple models
Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P130
Published Online: 2014-11-06
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Weir, Genevieve
Hrytsenko, Olga
Stanford, Marianne
Berinstein, Neil
Liwski, Robert
Karkada, Mohan
Mansour, Marc
Article History
First Online: 6 November 2014